NCT07628647 Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
| NCT ID | NCT07628647 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Brain Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2026-06-10 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2026-06-10 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if the newly designed group self-management program is feasible to conduct and improves mental and behavioral health outcomes compared to a control group in people diagnosed with brain cancer. The main questions it aims to answer are: * Is it feasible to conduct this program? * Does the new group self-management program improve behavioral health outcomes more than in the control group that will not be in a group setting?
Eligibility Criteria
Inclusion Criteria: * Currently living in the United States * Aged 18 years or older * Confirmed diagnosis of a malignant brain tumor including diffuse gliomas, World Health Organization (WHO) grades II, III, and IV (either by directly sharing their pathology report or confirmation from their prescribing treating provider) * Treating prescribing provider who follows regularly with participant Exclusion Criteria: * \<1 month since initial diagnosis and/or \<1 month since surgical resection * Enrollment in hospice * Significant physical or cognitive disabilities that prohibit involvement using our clinician's judgement as a self-management expert, with consultation with personal clinician if needed * Currently receiving psychiatric treatment for a serious mental illness (e.g., schizophrenia) * Not able to communicate in English at a conversational level
Contact & Investigator
Bethany M Kwan, PhD, MSPH
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT07628647 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07628647 currently recruiting?
Yes, NCT07628647 is actively recruiting participants. Contact the research team at lwbc@cuanschutz.edu for enrollment information.
Where is the NCT07628647 trial being conducted?
This trial is being conducted at Aurora, United States, Cleveland, United States.
Who is sponsoring the NCT07628647 clinical trial?
NCT07628647 is sponsored by University of Colorado, Denver. The principal investigator is Bethany M Kwan, PhD, MSPH at University of Colorado, Denver. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.